2023
DOI: 10.21203/rs.3.rs-3574950/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

SARS-CoV-2 infection status in corneal preservation solution and COVID-19 prevalence after corneal transplantation

Yuki Wasai,
Naoyuki Yamada,
Nobuaki Ariyoshi
et al.

Abstract: The potential risks associated with organs from COVID-19-infected donors were unclear. To determine the SARS-CoV-2 infection status of corneas transplanted during the COVID-19 pandemic, we performed a polymerase chain reaction (PCR) using the corneal preservation solution that was used for corneal transplantation. We also examined the postoperative health status of the recipients. This study included 144 transplants in 143 eyes. Ninety-nine eyes of imported corneas and 10 of the 14 corneas donated in the prefe… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…The importance of addressing this concern is twofold; not only does it bear significance for patient care but it also has implications for the formulation of vaccination guidelines for individuals awaiting or having undergone corneal transplantation. Consequently, there is an urgent need to thoroughly examine the existing evidence to determine the relationship between COVID-19 vaccination and the risk of corneal transplant rejection [14][15][16][17]. While previous systematic reviews have delved into the characteristics and outcomes of corneal transplant rejection in the context of COVID-19 vaccination [18,19], there still needs to be a gap in the literature regarding a comprehensive assessment of the risk associated with corneal graft rejection post-vaccination.…”
Section: Introductionmentioning
confidence: 99%
“…The importance of addressing this concern is twofold; not only does it bear significance for patient care but it also has implications for the formulation of vaccination guidelines for individuals awaiting or having undergone corneal transplantation. Consequently, there is an urgent need to thoroughly examine the existing evidence to determine the relationship between COVID-19 vaccination and the risk of corneal transplant rejection [14][15][16][17]. While previous systematic reviews have delved into the characteristics and outcomes of corneal transplant rejection in the context of COVID-19 vaccination [18,19], there still needs to be a gap in the literature regarding a comprehensive assessment of the risk associated with corneal graft rejection post-vaccination.…”
Section: Introductionmentioning
confidence: 99%